Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Halloran

Showing results (171-180 of 265) with videos related to

Pageof 27
Sort By:
Journal of Clinical Gastroenterology|November 13, 2014
Outpatient Ulcerative Colitis Primary Anti-TNF Responders Receiving Adalimumab or Infliximab Maintenance Therapy Have Similar Rates of Secondary Loss of ResponseChristopher Ma, Vivian Huang, Darryl K Fedorak, et al.
BMJ (Clinical Research Ed.)|August 13, 2015
Use of faecal occult blood tests in symptomatic patientsRobert Steele, Ian Forgacs, Gwyn McCreanor, et al.
British Journal of Cancer|November 3, 2017
Risk-adjusted colorectal cancer screening using the FIT and routine screening data: development of a risk prediction modelJennifer Anne Cooper, Nick Parsons, Chris Stinton, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 19, 2004
PTH differentially regulates expression of RANKL and OPGJohn C Huang, Takeshi Sakata, Laura L Pfleger, et al.
BMC Gastroenterology|September 14, 2016
Using a hypothetical scenario to assess public preferences for colorectal surveillance following screening-detected, intermediate-risk adenomas: annual home-based stool test vs. triennial colonoscopyBernardette Bonello, Alex Ghanouni, Harriet L Bowyer, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|May 3, 2016
FIT for the future: a case for risk-based colorectal cancer screening using the faecal immunochemical testJ A Cooper, S M Moss, S Smith, et al.
Alimentary Pharmacology & Therapeutics|September 5, 2014
Adalimumab dose escalation is effective for managing secondary loss of response in Crohn's diseaseC Ma, V Huang, D K Fedorak, et al.
Journal of the American Board of Family Medicine : JABFM|October 19, 2023
Failure to Participate in Sports: An Evaluation of Preparticipation Physicals in a Local School DistrictNamita Bhardwaj, Grant S Pierre, Alexandra P Halloran, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 1, 1994
Alendronate increases skeletal mass of growing rats during unloading by inhibiting resorption of calcified cartilageD D Bikle, E R Morey-Holton, S B Doty, et al.
Journal of Medical Screening|September 19, 2013
Patient attitudes towards faecal immunochemical testing for haemoglobin as an alternative to colonoscopic surveillance of groups at increased risk of colorectal cancerHarriet L Bowyer, Gemma Vart, Ines Kralj-Hans, et al.
Pageof 27

Showing results (171-180 of 265) with videos related to

Sort By:
Pageof 27
Journal of Clinical Gastroenterology|November 13, 2014
Outpatient Ulcerative Colitis Primary Anti-TNF Responders Receiving Adalimumab or Infliximab Maintenance Therapy Have Similar Rates of Secondary Loss of ResponseChristopher Ma, Vivian Huang, Darryl K Fedorak, et al.
BMJ (Clinical Research Ed.)|August 13, 2015
Use of faecal occult blood tests in symptomatic patientsRobert Steele, Ian Forgacs, Gwyn McCreanor, et al.
British Journal of Cancer|November 3, 2017
Risk-adjusted colorectal cancer screening using the FIT and routine screening data: development of a risk prediction modelJennifer Anne Cooper, Nick Parsons, Chris Stinton, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 19, 2004
PTH differentially regulates expression of RANKL and OPGJohn C Huang, Takeshi Sakata, Laura L Pfleger, et al.
BMC Gastroenterology|September 14, 2016
Using a hypothetical scenario to assess public preferences for colorectal surveillance following screening-detected, intermediate-risk adenomas: annual home-based stool test vs. triennial colonoscopyBernardette Bonello, Alex Ghanouni, Harriet L Bowyer, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|May 3, 2016
FIT for the future: a case for risk-based colorectal cancer screening using the faecal immunochemical testJ A Cooper, S M Moss, S Smith, et al.
Alimentary Pharmacology & Therapeutics|September 5, 2014
Adalimumab dose escalation is effective for managing secondary loss of response in Crohn's diseaseC Ma, V Huang, D K Fedorak, et al.
Journal of the American Board of Family Medicine : JABFM|October 19, 2023
Failure to Participate in Sports: An Evaluation of Preparticipation Physicals in a Local School DistrictNamita Bhardwaj, Grant S Pierre, Alexandra P Halloran, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 1, 1994
Alendronate increases skeletal mass of growing rats during unloading by inhibiting resorption of calcified cartilageD D Bikle, E R Morey-Holton, S B Doty, et al.
Journal of Medical Screening|September 19, 2013
Patient attitudes towards faecal immunochemical testing for haemoglobin as an alternative to colonoscopic surveillance of groups at increased risk of colorectal cancerHarriet L Bowyer, Gemma Vart, Ines Kralj-Hans, et al.
Pageof 27